1,064
Participants
Start Date
May 27, 2014
Primary Completion Date
April 4, 2017
Study Completion Date
May 18, 2021
Lotus Valve System
The Lotus Valve System is indicated to improve aortic valve function for symptomatic subjects with severe calcific aortic stenosis (aortic valve area \[AVA\] of \<1.0 cm2 or index of \<0.6 cm2/m2) who are at high risk for standard surgical valve replacement.
Waikato Hospital, Hamilton
Dept. of Cardiology Sint-Antonius ziekenhuis, Nieuwegein
Haukeland universitetssjukehus, Bergen
Vivantes Klinikum im Friedrichshain, Berlin
Universitätsklinikum Rostock, Rostock
Charité Campus Virchow Klinikum, Berlin
Policlinica Gipuzkoa, San Sebastián
Ospedale San Raffaele, Milan
IRCC Policlinico San Donato, Milan
Turku University Hospital, Turku
Herz-Kreislauf-Zentrum Segeberger Kliniken GmbH, Bad Segeberg
Deutsches Herzzentrum Berlin, Berlin
Hospital Universitario La Paz, Madrid
Azienda Ospedaliera Universtitaria di Padova, Padua
Rabin Medical Center, Petah Tikva
Universitätsklinikum Bonn, Bonn
Herz- und Gefäß-Klinik Bonn, Bonn
HELIOS Clinic, Siegburg
Azienda Ospedaliera Universtiatia Pisana (AOUP) Ospedale Cisanello, Pisa
Universitätsklinikum Ulm, Ulm
Krankenhaus d. Barmherzigen Brüder, Trier
Deutsches Herzzentrum München, Munich
University Hospital Munich, Munich
Fundacion Cardiovascular de Colombia, Floridablanca
Angiografia de Occidente S.A., Santiago de Cali
Asklepios Klinik St. Georg, Hamburg
Erasmus Medical Center, Rotterdam
Helsinki University Central Hospital/Meilahti Hospital, Helsinki
Herzzentrum Universitat Leipzig, Leipzig
I Klinika Kardiologii Uniwersytetu Medycznego W Poznaiu, Poznan
National Institute of Cardiology, Warsaw
Sahlgrenska University Hospital, Gothenburg
INSELSPITAL - Universitätsspital Bern, Bern
John Radcliffe Infirmary Oxford II, Oxford
Royal Sussex County Hospital, Brighton
Leeds Teaching Hospitals NHS, Leeds
Glenfield Hospital, Leicester
Clinical Trials Practitioner, London
King's College Hospital London, London
Cardiovascular & Cell Sciences Research Institute, London
New Cross Hospital, Wolverhampton
Lead Sponsor
Boston Scientific Corporation
INDUSTRY